Relationship of reduced cerebral blood flow and heart failure severity in elderly males

Introduction. Brain detrimental effects are under-recognised complication of chronic heart failure (CHF). One of the major causes may be cerebral hypoperfusion. This study was designed to investigate the relationship between cerebral blood flow (CBF) and severity of CHF as well as to evaluate its determinants among different parameters of cardiac dysfunction. Methods. Seventy-one CHF males with NYHA class II and III and 20 control subjects age ≥ 55 years were recruited. CBF was evaluated by colour duplex sonography of extracranial arteries. Echocardiography, 6-min walk test, quality of life and endothelial function were also assessed. Serum NT-pro-BNP and adipokines levels (adiponectin and leptin) were measured. Results. CBF was significantly reduced in elderly patients with CHF compared to healthy controls (677 ± 170 vs 783 ± 128 ml/min, p = 0.011). Reduced CBF was associated with reduced left ventricular ejection fraction (LVEF) (r = 0.271, p = 0.022), lower 6-min walk distance (r = 0.339, p = 0.004), deteriorated quality of life (r = −0.327, p = 0.005), increased serum adiponectin (r = −0.359, p = 0.002), and NT-pro-BNP levels (r = −0.375, p = 0.001). In multivariate regression analysis, LVEF and adiponectin were independently associated with reduced CBF in CHF patients (R2 = 0.289). Conclusion. CBF was reduced in elderly males with mild-to-moderate CHF, and was associated with factors that represent the severity of CHF including high serum adiponectin and NT-pro-BNP levels, decreased LVEF, impaired physical performance, and deteriorated quality of life.

[1]  O. Melander,et al.  Carotid Intima-Media Thickness, Systemic Inflammation, and Incidence of Heart Failure Hospitalizations , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[2]  L. Arnolda,et al.  Contributors to cognitive impairment in congestive heart failure: a pilot case–control study , 2009, Internal medicine journal.

[3]  H. Lee,et al.  Endothelial Function in Lacunar Infarction: A Comparison of Lacunar Infarction, Cerebral Atherosclerosis and Control Group , 2009, Cerebrovascular Diseases.

[4]  H. Okamoto Can adiponectin be a novel metabolic biomarker for heart failure? , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[5]  R. Harper,et al.  Brain injury in autonomic, emotional, and cognitive regulatory areas in patients with heart failure. , 2009, Journal of cardiac failure.

[6]  Shunichi Homma,et al.  Echocardiography-guided interventions. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  G. Burke,et al.  Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: the Cardiovascular Health Study. , 2008, Atherosclerosis.

[8]  S. Ibayashi,et al.  Renal and carotid vascular resistance assessed with Doppler sonography , 2008, Journal of clinical ultrasound : JCU.

[9]  B. Winblad,et al.  Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. , 2006, Archives of internal medicine.

[10]  Jae Seung Kim,et al.  Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. , 2006, The American journal of cardiology.

[11]  Y. Sharabi,et al.  Circulating adiponectin concentrations in patients with congestive heart failure , 2006, Heart.

[12]  Jan Frystyk,et al.  Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure , 2005, Circulation.

[13]  E. Lonn,et al.  Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. , 2005, Journal of the American College of Cardiology.

[14]  Stuart D Katz,et al.  Vascular Endothelial Dysfunction and Mortality Risk in Patients With Chronic Heart Failure , 2005, Circulation.

[15]  J. Viikari,et al.  Interrelations Between Brachial Endothelial Function and Carotid Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study , 2004, Circulation.

[16]  G. Román Brain hypoperfusion: a critical factor in vascular dementia , 2004, Neurological research.

[17]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[18]  F. Krummenauer,et al.  Lack of association between carotid artery volume blood flow and cardiac output. , 2001, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[19]  O. Almeida,et al.  Congestive heart failure and cognitive functioning amongst older adults. , 2001, Arquivos de neuro-psiquiatria.

[20]  F. Verheugt,et al.  Alterations in the peripheral circulation in patients with mild heart failure. , 2001, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[21]  A. Staniforth,et al.  Cognitive impairment in heart failure with Cheyne-Stokes respiration , 2001, Heart.

[22]  R Erbel,et al.  Tei-index in patients with mild-to-moderate congestive heart failure. , 2000, European heart journal.

[23]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[24]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[25]  H. Osada,et al.  Measurement of cerebral blood flow with two-dimensional cine phase-contrast mR imaging: evaluation of normal subjects and patients with vertigo. , 1995, Radiation medicine.

[26]  D. Morris,et al.  The Impact of Cardiac Index on Cerebral Hemodynamics , 1993, Stroke.

[27]  William J. Rogers,et al.  Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction , 1993 .

[28]  Bittner,et al.  Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. , 1993, JAMA.

[29]  D. Graham,et al.  Endothelin-1-Induced Reductions in Cerebral Blood Flow: Dose Dependency, Time Course, and Neuropathological Consequences , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  J. Cohn,et al.  Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. , 1992, American heart journal.

[31]  H. Drexler,et al.  Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. , 2005, European heart journal.

[32]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[33]  P. Scheel,et al.  Color duplex measurement of cerebral blood flow volume in healthy adults. , 2000, Stroke.

[34]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .